These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 29247711

  • 41. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
    Li X, Zhang L, Yu L, Wei W, Lin X, Hou X, Tian Y.
    J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
    [Abstract] [Full Text] [Related]

  • 42. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y, Yun Y, Wu B, Wen L, Wen M, Yang H, Zhao L, Liu W, Huang S, Wen N, Li Y.
    Oncotarget; 2016 Jul 26; 7(30):47985-47997. PubMed ID: 27351131
    [Abstract] [Full Text] [Related]

  • 43. ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.
    Bao L, Wu J, Dodson M, Rojo de la Vega EM, Ning Y, Zhang Z, Yao M, Zhang DD, Xu C, Yi X.
    Mol Carcinog; 2017 Jun 26; 56(6):1543-1553. PubMed ID: 28112439
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
    Ikeda S, Abe F, Matsuda Y, Kitadate A, Takahashi N, Tagawa H.
    Cancer Sci; 2020 Nov 26; 111(11):4088-4101. PubMed ID: 32790954
    [Abstract] [Full Text] [Related]

  • 46. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2.
    Cui Y, Qin L, Tian D, Wang T, Fan L, Zhang P, Wang Z.
    Chemotherapy; 2018 Nov 26; 63(5):262-271. PubMed ID: 30481785
    [Abstract] [Full Text] [Related]

  • 47. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP, Wang LP, Hong ZS, Qiu CZ, Wang MZ, Chen ZX, Tang LF, Yu WS, Wang CX.
    Int J Oncol; 2018 Sep 26; 53(3):1183-1192. PubMed ID: 30015866
    [Abstract] [Full Text] [Related]

  • 48. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
    Wang R, Ma X, Su S, Liu Y.
    Future Med Chem; 2018 Aug 01; 10(16):1947-1955. PubMed ID: 29966441
    [Abstract] [Full Text] [Related]

  • 49. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):285-92. PubMed ID: 27116987
    [Abstract] [Full Text] [Related]

  • 50. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y, Zheng X, Lu J, Chen W, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Apr 25; 45(6):2548-2559. PubMed ID: 29558748
    [Abstract] [Full Text] [Related]

  • 51. Cross-reacting material 197, a heparin-binding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer.
    Tang XH, Li M, Deng S, Lu MS.
    Anticancer Drugs; 2014 Nov 25; 25(10):1201-10. PubMed ID: 25115341
    [Abstract] [Full Text] [Related]

  • 52. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 25; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 53. The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
    Wu W, Yu LH, Ma B, Xu MJ.
    PLoS One; 2014 Sep 25; 9(3):e89841. PubMed ID: 24598933
    [Abstract] [Full Text] [Related]

  • 54. PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.
    Zhu X, Ji M, Han Y, Guo Y, Zhu W, Gao F, Yang X, Zhang C.
    Int J Oncol; 2017 Mar 25; 50(3):835-846. PubMed ID: 28197632
    [Abstract] [Full Text] [Related]

  • 55. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J, Shi HR, Ren F, Wang JL, Wu QH, Li X, Zhang RT.
    BMC Cancer; 2017 Dec 14; 17(1):851. PubMed ID: 29241458
    [Abstract] [Full Text] [Related]

  • 56. Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells.
    Kulshrestha A, Katara GK, Ginter J, Pamarthy S, Ibrahim SA, Jaiswal MK, Sandulescu C, Periakaruppan R, Dolan J, Gilman-Sachs A, Beaman KD.
    Mol Oncol; 2016 Jun 14; 10(6):789-805. PubMed ID: 26899534
    [Abstract] [Full Text] [Related]

  • 57. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y.
    Oncol Rep; 2016 Apr 14; 35(4):2466-72. PubMed ID: 26794135
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
    Park J, Park SY, Kim JH.
    Biochim Biophys Acta; 2016 Feb 14; 1863(2):236-43. PubMed ID: 26597704
    [Abstract] [Full Text] [Related]

  • 60. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y, Jiang J, Jia H, Qiao Z, Zhang J.
    Cell Physiol Biochem; 2018 Feb 14; 51(1):129-141. PubMed ID: 30439707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.